In 2023, the re-import value of composite diagnostic or laboratory reagents to the UK stood at an estimated 1.3700 million USD. The forecast from 2024 to 2028 predicts a gradual decline in this value, decreasing from 1.3405 million USD in 2024 to 1.2369 million USD by 2028. Year-on-year, the market is expected to diminish, with an average annual decrease highlighted by a negative CAGR over five years.
Future trends to watch include technological advancements, regulatory shifts, and supply chain improvements, which could influence the re-import levels of these reagents to the UK. Market players should monitor global demand and emerging biotechnologies that might impact this sector.
